NCT00379821View on ClinicalTrials.gov

Chloroquine Alone or in Combination for Malaria in Children in Malawi

PHASE3CompletedINTERVENTIONAL
Enrollment

640

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2012

Conditions
Plasmodium Falciparum Infection
Interventions
DRUG

Atovaquone-proguanil

Atovaquone-proguanil: once a day for 3 days, Pediatric tablet: 62.5 mg/25 mg, Full strength tablet: 250 mg/100 mg

DRUG

Artesunate

Artesunate: 4mg/kg once a day for 3 days, 50 mg tablet

DRUG

Azithromycin

Azithromycin 30 mg/kg once a day for 3 days, 200 mg/5cc suspension

DRUG

Chloroquine

Chloroquine: 10 mg/kg on days 0 and 1, 5 mg/kg/day on day 2, 100 mg tablet.

Trial Locations (1)

Unknown

Blantyre Malaria Project - Ndirande Health Centre, Blantyre

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00379821 - Chloroquine Alone or in Combination for Malaria in Children in Malawi | Biotech Hunter | Biotech Hunter